CRISPR Therapeutics AG (CRSP) Capital Expenditures Growth (1y) (2016 - 2026)
CRISPR Therapeutics AG (CRSP) Capital Expenditures Growth (1y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
CRISPR Therapeutics AG |
5.21 Bn |
2.76 Bn |
- |
144.66% |
| Date | Value |
|---|
| Mar 31, 2026 |
144.66% |
| Dec 31, 2025 |
134.63% |
| Sep 30, 2025 |
-66.21% |
| Jun 30, 2025 |
-83.45% |
| Mar 31, 2025 |
-71.43% |
| Dec 31, 2024 |
-302.30% |
| Sep 30, 2024 |
-89.66% |
| Jun 30, 2024 |
-82.24% |
| Mar 31, 2024 |
-72.62% |
| Dec 31, 2023 |
-97.71% |
| Sep 30, 2023 |
110.56% |
| Jun 30, 2023 |
-79.15% |
| Mar 31, 2023 |
-55.28% |
| Dec 31, 2022 |
-57.23% |
| Sep 30, 2022 |
-1,480.85% |
| Jun 30, 2022 |
1,552.97% |
| Mar 31, 2022 |
-33.45% |
| Dec 31, 2021 |
966.44% |
| Sep 30, 2021 |
-113.31% |
| Jun 30, 2021 |
-205.54% |
